Concepedia

Lingqin Yuan

LY

Statistics

Publications

4

Citations

216

H-Index

4

Active since

2015

Affiliations

Shandong First Medical University(Current)

Shandong Tumor Hospital

University of North Carolina at Chapel Hill

Chinese Academy of Medical Sciences & Peking Union Medical College

University of North Carolina Hospitals

Lingqin Yuan is an author at Shandong First Medical University specializing in medicine, oncology, and cancer cell proliferation inhibition.

ORCID

Publications per year

2015–2023

4

Publications

4

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway

Lingqin Yuan, Xiugui Sheng, Adam K. Willson et al. · Endocrine Related Cancer · 2015 · 109 citations · Full text

, , +15

Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer

Chunxiao Zhou, Hui Guo, Adam K. Willson et al. · PubMed · 2020 · 71 citations

, , +17

Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy

Hui Guo, Shuai Feng, Zhiqiang Li et al. · Journal of Inflammation Research · 2023 · 19 citations · Full text

, , +17

The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivoAnti-tumor Effects in Endometrial Cancer

Xiugui Sheng, Lingqin Yuan, Hui Guo et al. · Anti-Cancer Agents in Medicinal Chemistry · 2022 · 17 citations

, , +15

1–4 of 4